NPPB and hydrops fetalis: In a detailed analysis from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF), it was observed that the baseline levels of ET-1 were linked to increased in-hospital adverse events and mortality at three months in patients admitted with acute HF, adding to the prognostic value provided by NT-proBNP [31].